
Pharmacally
Disease & Drugs
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Disease & Drugs
New Drug Approval“Teal Wand Becomes First FDA Approved At Home Cervical Cancer Screening Device for High-Risk HPV – A Breakthrough for Women’s Health”On May 9, 2025, the U.S. Food and Drug Administration (FDA) approved the Teal Wand medical device.Fact-Checked
New Drug Approval“England Rolls Out 5-Minute Subcutaneous Opdivo (Nivolumab) for 15+ Cancer Types, Enhancing Treatment Speed and Patient Convenience”Written by Priyanka Khamkar (M. Pharm) Pharmacology and Vikas Londhe M.Pharm, Pharmacology Source: Freepik.com The UK’s National Health Service (NHS)…Fact-Checked
New Drug ApprovalTepezza (Teprotumumab) A first Targeted Drug Receives Positive CHMP Opinion from EMA and Approval from MHRA to Treat Moderate to Severe Thyroid Eye Disease (TED) by Targeting IGF-1 ReceptorSource: Freepik.com Written by: Shakuntala Kawhale (Pharmacology The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…Fact-Checked
New Drug ApprovalQoyvolma: A More Affordable Biologic Option for Plaque Psoriasis and Inflammatory Diseases like Psoriatic Arthritis, Cohn’s Disease, and Ulcerative ColitisWritten by Rikesh Dighore (Pharmacology) and Soniya Hajare (Pharmacology) Source: Freepik.com The European Medicines Agency’s (EMA) Committee for Medicinal Product…Fact-Checked
New Drug ApprovalEMA’s CHMP Recommends Sephience (sepiapterin) for Hyperphenylalaninaemia (HPA) in Adults and Children with Phenylketonuria (PKU)The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has accepted a positive opinion recommending the approval of Sephience (sepiapterin) for the…Fact-Checked
New Drug ApprovalFDA Grants Accelerated Approval to Novartis’ Vanrafia (Atrasentan): First and Only Endothelin-1 Receptor Blocker for Proteinuria Reduction in IgA Nephropathy (IgAN)The U.S. Food and Drug Administration (FDA) have granted accelerated approval to Novartis Pharmaceuticals Corporation for Vanrafia (atrasentan).Fact-Checked
New Drug ApprovalFDA Approves Imaavy (nipocalimab-aahu), a Neonatal Fc Receptor (FcRn) Blocker, Offering New Hope for People Living with Generalized Myasthenia Gravis (gMG)Written by Priya Bhaware (M.Pharm. Pharmacology) Source: Freepik.com The Food and Drug Administration approved Imaavy (Nipocalimab-aahu) for the treatment of…Fact-Checked
New Drug ApprovalFDA Approval of Atzumi Marks a New Era in Migraine Treatment with SMART MucoAdhesive DeliveryThe U.S. Food and Drug Administration (FDA) have approved Atzumi (dihydroergotamine mesylate) nasal powder for the acute treatment of adult migraine with or without aura, marking a major…Fact-Checked
New Drug ApprovalFDA Approves PD-1 Inhibitor Penpulimab-kcqx for Advanced Nasopharyngeal Carcinoma (NPC)In the landmark development, U.S. Food and Drug Administration have approved innovative PD-1 monoclonal antibody, penpulimab-kcqx, in combination with cisplatin or carboplatin and gemcitabine for the initial treatment…Fact-Checked
New Drug ApprovalFDA Approves Zevaskyn (Prademagene Zamikeracel) for Recessive Dystrophic Epidermolysis Bullosa (RDEB): Gene Therapy Targets COL7A1 Gene and Boosts Type VII Collagen (C7)For the treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB), the FDA has approved Zevaskyn (prademagene zamikeracel), the first autologous cell-based gene therapy.Fact-Checked
New Drug ApprovalFDA Grants Accelerated Approval to Avmapki Fakzynja Co-Pack for KRAS-Mutated Low Grade Serous Ovarian Cancer (LGSOC) Targeting RAS/MAPK PathwayIn a significant progress in ovarian cancer treatment, the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Avmapki Fakzynja Co-Pack (avutometinib capsules and defactinib tablets)…Fact-Checked
New Drug ApprovalJapan First-in-the-World to approve Elevidys (Delandistrogene Moxeparvovec), one-of-the Costliest Gene Therapy Drug for Duchenne Muscular Dystrophy (DMD) in Children less than 4 years of ageIn a groundbreaking step forward for genetic medicine, Japan has become the first country in the world to approve the use of Elevidys (delandistrogene moxeparvovec), a gene therapy…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.